3.75
前日終値:
$5.26
開ける:
$5.15
24時間の取引高:
186.36K
Relative Volume:
4.71
時価総額:
$5.58M
収益:
$27.40M
当期純損益:
$-17.12M
株価収益率:
-0.0351
EPS:
-106.8896
ネットキャッシュフロー:
$-24.99M
1週間 パフォーマンス:
-20.55%
1か月 パフォーマンス:
-35.34%
6か月 パフォーマンス:
+30.21%
1年 パフォーマンス:
-68.03%
Dna X Inc Stock (SONM) Company Profile
Compare SONM vs MSFT, ORCL, PLTR, FTNT, NET
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
SONM
Dna X Inc
|
3.75 | 7.66M | 27.40M | -17.12M | -24.99M | -106.89 |
|
MSFT
Microsoft Corp
|
390.49 | 2.77T | 318.27B | 125.22B | 72.92B | 16.79 |
|
ORCL
Oracle Corp
|
140.27 | 422.13B | 64.08B | 16.40B | -24.74B | 5.5698 |
|
PLTR
Palantir Technologies Inc
|
129.30 | 279.69B | 5.22B | 2.29B | 2.69B | 0.8876 |
|
FTNT
Fortinet Inc
|
156.25 | 112.55B | 7.11B | 1.95B | 2.44B | 2.5883 |
|
NET
Cloudflare Inc
|
242.41 | 87.06B | 2.33B | -86.74M | 291.77M | -0.2483 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-10-31 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-07-18 | 開始されました | B. Riley FBR | Buy |
| 2019-07-09 | アップグレード | National Securities | Neutral → Buy |
| 2019-06-10 | 開始されました | National Securities | Neutral |
| 2019-06-04 | 開始されました | Lake Street | Buy |
| 2019-06-04 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Dna X Inc (SONM) 最新ニュース
Cisco Catalyst 9300 Series Switches from Cisco Systems Inc.subscription-first campus networking p - AD HOC NEWS
Nextera Library Preparation Kit from Takara Holdings Incstreamlined NGS workflows for busy labs - AD HOC NEWS
Study: Gen-Z and Millennials Are Aging Faster Than Their Parents—With Alarming Health Consequences - inc.com
Price to book forward of DNA X, Inc. – NASDAQ:SONM - TradingView
Price to earnings forward of DNA X, Inc. – NASDAQ:SONM - TradingView
Price to sales forward of DNA X, Inc. – NASDAQ:SONM - TradingView
12 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga
How DNA's Double Helix Structure Was Discovered - Encyclopedia Britannica
Enterprise value to revenue forward of DNA X, Inc. – MUN:J6P - TradingView
Alex Murdaugh defense points to unknown male DNA in push for new testing - 930 WFMD Free Talk
SONM Q3 2024 Earnings: Loss Narrows Significantly, Beats ExpectationsEarnings Miss Streak - newsline.com
Ginkgo Bioworks (DNA) director Harry Sloan awarded 25,000 RSUs - Stock Titan
[EFFECT] DNA X, Inc. SEC Filing - Stock Titan
DNA X | EFFECT: Others - Moomoo
DNA X Inc. (SONM) Faces Downside Pressure as Support Levels ApproachRVOL Spike - newsline.com
DNA X (SONM) deregisters 350M common shares tied to Chardan resale - Stock Titan
DNA Research Shows Your Muscles Remember How Strong and Fit You Once Were - inc.com
11 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session - Benzinga
DNA X, Inc. (formerly Sonim Technologies) Terminates Material Definitive Agreement – SEC Form 8-K Filing June 2026 - Minichart
Sonim Technologies Ends Major Equity Purchase Agreement - TipRanks
12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga
DNA X Ends $500 Million ChEF Equity Facility and Related Registration Rights With Chardan - TradingView
DNA X (NASDAQ: SONM) terminates $500M Chardan equity facility - Stock Titan
Natera Inc stock (US6323071042): insider sales and new oncology board appointments in focus - AD HOC NEWS
DNA X: Q1 Earnings Snapshot - AOL.com
Lotus Technology Inc. Unveils Eletre X: A Revolutionary Hybrid SUV Offering 1,200+ km Range and Supercar Performance Starting at €96,990 - Quiver Quantitative
12 Information Technology Stocks Moving In Tuesday's Intraday Session - Benzinga
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights - Business Wire
SONMDNA X Inc Short Interest - Finviz
SONM Q3 2024 Earnings: EPS Surprises to the Upside with 22.76% Beat; Stock Rises 4%Preliminary Results - The Legal Advocate
SONM Q3 2024 Earnings: EPS Surprises Higher by 22.76%, Stock Rises Over 4%One-Time Gain Impact - The Legal Advocate
SONM Q3 2024 Earnings: EPS Beats Estimates by 22.76% Amid Cost DisciplineRetail Earnings Report - thelegaladvocate.com
DNA X Inc. (SONM) Shares Rise Nearly 6% as Buyer Interest Surges Near Key SupportGrowth ETF - newsline.com
S&P 500 Edges Higher as Healthcare and Tech Rally Outweigh Utility DeclinePPI Inflation Report - thelegaladvocate.com
DNA X Inc. (SONM) Rallies 4.18% as Momentum Builds Toward Key ResistanceEntry Point Alerts - The Legal Advocate
DNA X, Inc. Enters Securities Purchase Agreement with DNA Holdings Venture, Inc. and Issues Convertible Note – Key Details and Terms - Minichart
DNA X Stock Looks at Nasdaq Deadline After Latest Financing - Bez Kabli
Sonim Technologies Faces Nasdaq Delisting After New Financing - TipRanks
DNA X Received Notice of Delisting - TradingView
CIA Accused of Searching Ancestry DNA for "Alien Genetics" - hypefresh.com
Why people are losing it over Ferrari’s first all-electric car - Fast Company
DNAGinkgo Bioworks Holdings Inc Stock Price and Quote - Finviz
DNA X, Inc. announced that it has received $3.052788 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
DNA X Inc. (SONM) Q3 2024 Earnings: EPS Beats Estimates, Stock Surges 13.71%Community Hot Stocks - Newser
A Mild and DNA-Compatible Cyclization Strategy for the Construction of [1,2,4]Triazolo[1,5-a]pyridine Scaffolds - ACS Publications
DNA X Inc. (SONM) Surges 13% as Buyer Demand Tests Key Resistance at $4.68Institutional Grade Picks - Newser
Ginkgo Bioworks Holdings Inc (DNA): What’s the Future of Autonomous Lab? - Yahoo Finance Singapore
12 Information Technology Stocks Moving In Thursday's Intraday SessionAmplitech Group, Inc.Series A - Benzinga
DNA X, Inc. (SONM) Reports Q1 2026 Financial Results, Completes Mobile Business Sale, and Focuses on AI Crypto Trading Platform - Minichart
DNA X, Inc. Reports First Quarter 2026 Financial Results - Scott Coop
Dna X Inc (SONM) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):